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Modular automated solid phase synthesis of
dermatan sulfate oligosaccharides†
Jeyakumar Kandasamy,a Frank Schuhmacher,ab Heung Sik Hahm,ab James C. Kleina
and Peter H. Seeberger*ab
Dermatan sulfates are glycosaminoglycan polysaccharides that serve
a multitude of biological roles as part of the extracellular matrix.
Orthogonally protected D-galactosamine and L-iduronic acid building
blocks and a photo-cleavable linker are instrumental for the auto-
mated synthesis of dermatan sulfate oligosaccharides. Conjugation-
ready oligosaccharides were obtained in good yield.
Dermatan sulfate is a glycosaminoglycan (GAG) predominantly
found in skin and present in many mammalian tissues.1 It is
composed of disaccharide repeating units consisting of N-acetyl-D-
galactosamine (GalNAc) and L-iduronic acid (IdoA). These alternating
disaccharide units can be variably O-sulfated at the C-4 and C-6
positions in GalNAc, and the C-2 position in IdoA.2 Depending on
the source, 63–97% of the dermatan sulfate polymer is made up
of IdoA - GalNAc4SO3 disaccharide repeating units that are
considered to be characteristic of dermatan sulfate (Fig. 1).3
Dermatan sulfate binds to a variety of proteoglycans and
modulates various biological processes such as coagulation, angio-
genesis, tumor migration and growth factor expression.4,5 Specific
biological roles of dermatan sulfate are poorly understood due
to the variations and heterogeneity in its polymer structure.6,7
In order to establish structure–activity relationships for dermatan
sulfate sequences, to correlate specific sequences and sulfation
patterns with protein binding and specific biological activities
access to structurally defined dermatan sulfate oligosaccharides
is required. Homogeneous samples of such fragments are acces-
sible only via chemical synthesis.
To date, syntheses of dermatan sulfate oligosaccharides have been
executed in solution phase relying on many manual operations.8–12
With appropriate building blocks in hand, automated solid phase
synthesis enables rapid access to structurally-defined oligo-
saccharides.13,14 Automated protocols for the synthesis of other
glycosaminoglycans such as hyaluronan15 and chondroitin sulfate
have been reported previously.16 Here, we describe the automated
solid phase synthesis of conjugation ready dermatan sulfate oligo-
saccharides aimed at developing additional tools for biological
studies of GAGs.
The dermatan sulfate backbone may arise via assembly of
orthogonally protected galactosamine (GalN) and iduronic acid
building blocks (1 and 2, Fig. 1) designed for automated solid
phase synthesis on solid supported photo-cleavable linker 3.16
The C-3 position of GalN and the C-4 position of IdoA are masked
Fig. 1 Structure of dermatan sulfate oligosaccharides and retrosynthetic
analysis.
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with the temporary 9-fluorenylmethoxycarbonyl (Fmoc) protecting
group in anticipation of the regiospecific elongation of the oligo-
saccharide chain. The C-4 position of GalN carries a levulinoyl ester
(Lev) that can be selectively cleaved under mild conditions to allow
for sulfation of the free hydroxyl group. The GalN amino group was
protected as trichloroacetamide to ensure good b-selectivities in
glycosylation reactions and allow for the installation of the desired
acetamide by the direct reduction at the late stage of the synthesis.
The C-2 hydroxyl group of the IdoA building block was protected as a
benzoate ester to ensure a-selectivity in glycosylation reactions. The
remaining hydroxyl groups that were not modified during the
assembly were permanently protected as benzyl ethers.
Owing to the high cost of galactosamine, these building blocks
are accessed from galactose via formation of galactal followed by
azido-selenation16,17 or from glucosamine via epimerization of the
C-4 position.8,9 Taking the latter approach into account, we pre-
pared building block 1 in nine steps from glucosamine via migra-
tion of a-ester with epimerization as the key step (Scheme 1).18,19
Thioglycoside 11 was synthesized in four steps from glucosamine
hydrochloride (see ESI†).20 Levulination of the free hydroxyl group
in 11 followed by regioselective ring opening of benzylidine acetal
using triethylsilane/trifluoroacetic acid yielded thioglycoside 12 in
70% yield over two steps. Migration of the C-3 Lev ester to the C-4
hydroxyl with epimerization was eﬀected by transforming the free
hydroxyl group in 12 to the corresponding triflate to produce
galactose thioglycoside 13 in 78% yield. Fmoc protection of the
free hydroxyl group in 13 followed by the conversion of thioglyco-
side to glycosyl phosphate using dibutyl hydrogen phosphate and
N-iodosuccinimide–triflic acid yielded differentially protected build-
ing block 1 in 86% yield.
Synthesis of IdoA building block 2 was achieved in five steps
from thioglycoside 1421 (Scheme 2). Tetrakis(triphenylphosphine)-
palladium(0) was employed for the deprotection of the allyl group
in thioglycoside 14 and the resulting hydroxyl group was protected
as a benzoyl ester to obtain thioglycoside 15 in 89% yield (over two
steps). Removal of the naphthyl group in 15 using 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ) followed by Fmoc protection of
the resulting alcohol provided thioglycoside 16 in 82% overall yield.
Thioglycoside 16 was then converted to the corresponding
phosphate glycoside 2 in 92% yield.
The simple non-sulfated dermatan oligosaccharides were
pursued first in order to test the ability of the automated route
to deliver the glycan backbone without deletion sequences. Di- and
tetra-saccharides 4 and 5 were prepared using the oligosaccharide
synthesizer via iterative glycosylations with building blocks 1 and 2
and linker 3 (Scheme 3). Glycosylations were carried out at tem-
peratures between 10 1C and 0 1C using trimethylsilyl trifluoro-
methanesulfonate (TMSOTf). Each cycle involved addition of a
glycosylating agent (double coupling) twice, using five equivalents
of building blocks. Removal of the Fmoc protecting group with
triethylamine uncovered the hydroxyl group ready for elongation.
Synthesis of disaccharide 4 commencedwith the first glycosylation–
deprotection cycle using building block 1 followed by the second
glycosylation–deprotection cycle using building block 2. The resulting
free hydroxyl group on the terminal sugar was then acetylated on the
synthesizer employing acetic anhydride in pyridine. Disaccharide 4was
released from the resin by applying UV light using a photo flow
reactor.16 The crude product was purified by HPLC to obtain 4 in 66%
overall yield for six steps based on resin loading. Tetrasaccharide 5
was assembled similarly via four glycosylation–deprotection cycles
by alternating use of building blocks 1 and 2, followed by the
acetylation of the free hydroxyl group on the terminal sugar. Upon
cleavage from the resin, the crude product was purified by HPLC to
obtain 6 in 28% overall yield (ten steps). No deletion sequences were
observed in the automated synthesis of 4 and 5 as judged by HPLC.
Automated synthesis of sulfated dermatan oligosaccharides
required two additional steps for installation of sulfates: selective
removal of the Lev protecting groups and sulfation of the resulting
hydroxyl groups. A solution of hydrazine acetate in pyridine–acetic
acid effected removal of the Lev groups at 25 1C. The pyridine sulfur
trioxide complex in dimethylformamide–pyridine was used for the
sulfation of free hydroxyl groups at 50 1C on the synthesizer.16
Synthesis of sulfated monosaccharide 6 and disaccharide 7 was
achieved on a solid support in five and seven automated steps,
respectively, under glycosylation–deprotection conditions estab-
lished for compounds 4 and 5, followed by automated acetylation,
Lev deprotection and sulfation as described above. After the cleavage
of the photo-sensitive linker, crude products were analysed by
reverse phase (RP)-HPLC and purified by size exclusion chromato-
graphy (Sephadex LH-20) to obtain monosaccharide 6 in 43% and
disaccharide 7 in 32% overall yield based on resin loading.
Automated assembly of sulfated tetrasaccharide 8 under the
conditions established for the synthesis of 6 and 7 yielded a
Scheme 1 Synthesis of galactosamine building block 1. Reagents and condi-
tions: (a) Lev2O, Py, 91%. (b) Et3SiH, TFA, MS (4 Å), 77%. (c) Tf2O, Py, 10 1C,
15 minutes; addition of H2O, reflux atB80 1C for 5 h, 78%. (d) FmocCl, Py, 93%.
(e) Dibutyl hydrogen phosphate, NIS-TfOH, MS (4 Å), 93%.
Scheme 2 Synthesis of iduronic acid building block 2. Reagents and
conditions: (a) Pd(Ph3)4, 1,3-dimethylbarbituric acid, MeOH, 91%. (b) BzCl,
Py, 98%. (c) DDQ, MeOH, 88%. (d) FmocCl, Py, 94%. (e) Dibutyl hydrogen
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mixture of compounds resulting from incomplete removal of
Lev esters with hydrazine acetate at 25 1C. Raising the tem-
perature for Lev deprotection to 40 1C in the automated run
improved the purity and yield of the desired tetrasaccharide 8
that was isolated in 12% yield over 12 steps.
After assembly of the protected oligosaccharides on the solid
support, deprotection of sulfated disaccharide 7 was tested in
solution phase (Scheme 4). Hydrolysis of acetate, benzoate and
methyl esters was achieved using lithium hydroxide/hydrogen
peroxide in THF–MeOH to obtain disaccharide 9 in 79% yield.
Hydrogenolysis of 9 provided fully deprotected, conjugation
ready disaccharide 10 in 80% yield.
In conclusion, an eﬃcient automated solid phase synthesis
of dermatan oligosaccharides was achieved using orthogonally
protected building blocks and a photo-cleavable linker as well
as an automated oligosaccharide synthesizer. Two-step depro-
tection in solution aﬀords the conjugation ready dermatan
sulfate oligosaccharides that can be directly immobilized on
microarrays or conjugated to proteins.
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Scheme 3 Automated synthesis of dermatan sulfate oligosaccharide backbones. Reagents and conditions: (a) TMSOTf, DCM, 10 to 0 1C. (b) 25% Et3N
in DMF, 25 1C. (c) Ac2O, Py, 25 1C. (d) NH2NH2HOAc, Py, AcOH 25 1C or 40 1C. (e) PySO3, DMF, Py, 50 1C. (f) UV irradiation using continuous flow reactor,
DCM–MeOH, RT.
Scheme 4 Deprotection of sulfated disaccharide 7. Reagents and conditions:
(a) 1 M LiOH, H2O2, THF–MeOH, 79%. (b) Pd–C, H2, 80%.
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